Updated Vorinostat Drug Summary

Source: U.S. Department of Health and Human Services, AIDSinfo
Published August 4, 2017

Vorinostat (Zolinza) is a drug that has been approved by the FDA for the treatment of cancer and is currently being studied as part of a possible strategy to cure HIV infection. Its drug summary has been updated and includes information on side effects, clinical trials, and more information on vorinostat-related research studies.

Click here to review the full drug summary.

Leave a Reply